The Journal of the Royal Society for the Promotion of Health · 2002 · 37 citations · 18 references
MedicinePharmacologyCardiovascular PharmacotherapyClinical PharmacologyDrug Approval ProcessesCardiovascular Drug SafetyDrug AdvertisingEssential MedicinesPharmaceutical MarketingRegulatory PharmacologyHerbal Product SafetyPrimary Hypertension
The market for non-conventional, natural herbal medicines is growing. This marketing opportunity has been seized upon by some unscrupulous practitioners to sell potentially unsafe 'herbal' products. Several people attended a Chinese herbalist for weight loss advice and were sold 'herbal' preparations that contained fenfluramine, a drug which was withdrawn from sale in the West in 1997 after its use was linked to primary pulmonary hypertension and valvular heart disease. Adulteration of Chinese medicines with Western drugs is becoming an increasing problem, and deaths have been reported from Japan and other Far Eastern countries linked to Chinese slimming aids containing N-nitroso-fenfluramine. There is a need for increased public awareness of such risks associated with the use of unlicensed medicines; a system of registration for medical herbalists is also required to protect both the reputable practitioners and the general public.
18
Trends in Alternative Medicine Use in the United States, 1990-1997
David M. Eisenberg, Roger B. Davis, Susan L. Ettner et al. · JAMA · 1998 · 6.7K citations
Recent Patterns of Medication Use in the Ambulatory Adult Population of the United States
David W. Kaufman, Judith P. Kelly, Lynn Rosenberg et al. · JAMA · 2002 · 1.8K citations
Valvular Heart Disease Associated with Fenfluramine–Phentermine
Heidi M. Connolly, Jack L. Crary, Michael D. McGoon et al. · New England Journal of Medicine · 1997 · 1.6K citations · Full text
Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension
Lucien Abenhaim, Yola Moride, François Brenot et al. · New England Journal of Medicine · 1996 · 1.2K citations · Full text